According to officials, the move comes as part of a larger state-wide quality enforcement drive aimed at tightening checks on oral liquid formulations, syrups, and suspensions—categories most often associated with recent toxic outbreaks. The MPFDA has already written to the CDSCO seeking joint inspections of all identified facilities to ensure “complete transparency and accountability.”
“We have written a letter requesting joint inspections of 30 units in Madhya Pradesh,” Dinesh Shrivastava, Controller of the MP Food and Drug Administration was quoted as saying by OCAcademy. He added that these inspections would assess compliance with safety, testing, and manufacturing standards to eliminate the risk of substandard or adulterated products reaching the market.
The regulator has also urged the Drug Controller General of India (DCGI) to make Diethylene Glycol (DEG) and Polyethylene Glycol (PEG) testing mandatory for all oral liquid preparations manufactured across India. Both solvents, when contaminated, have been linked to multiple poisoning incidents globally—including fatal cases in India—highlighting the urgent need for robust quality control mechanisms.
In the ongoing investigation, the MPFDA has collected 243 samples of cough syrups and oral formulations statewide, with laboratory testing currently in progress. Preliminary results have already declared three products—Coldrif, Respifresh TR, and Re Life—as substandard. Authorities have seized and frozen 1,086 bottles of these formulations to prevent their further distribution and sale, reports The Times of India.
The crackdown comes amid renewed global attention on India’s pharmaceutical manufacturing practices following recent contamination-linked child deaths.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.